Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2011

Sep 14, 2011

29745_dirs_2011-09-14_43e83ae4-283e-4bf0-927b-9830a1129e25.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2011-09-12

Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-08-26 Common Stock G 145 $0.00 Disposed 74153 Direct
2011-09-12 Common Stock S 5700 $35.91 Disposed 68453 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6755 Indirect

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011.